Two of the FDA’s senior vaccine officials are stepping down. The news comes as boosters and children’s shots are being weighed by the department. In a letter sent to staff and obtained by BioPharma Dive, the agency’s Center for Biologics Evaluation and Research announced the departure of Marion Gruber and Phil Krause, two of the FDA’s top vaccine reviewers, within the next two months. Gruber and Krause are reportedly leaving over the White House’s decision to begin administering booster shots the week of September 20th without the FDA completing its own review of approval for third shots.
If you would like to receive an e-mail notice of the most recent articles published in The Vaccine Reaction each week, click here.